NDC 71288-129
Dactinomycin
Dactinomycin
Dactinomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Dactinomycin.
| Product ID | 71288-129_d9bb02eb-3f9e-4932-bdcd-53b5bd6392b6 |
| NDC | 71288-129 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dactinomycin |
| Generic Name | Dactinomycin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-11-13 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA213463 |
| Labeler Name | Meitheal Pharmaceuticals Inc. |
| Substance Name | DACTINOMYCIN |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Actinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |